[败血症患者中细胞因子的表达水平及其对预后的影响]
Pingna Li1, Hongfu Yang, Qiumin Cui
1Department of Intensive Care Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. Corresponding author: Sun Rongqing,
Zhonghua wei zhong bing ji jiu yi xue
|December 27, 2023
概括
较高的APACHE II分数和IL-6水平预示着败血症患者的预后较差. 这项研究强调了这些标记,用于评估败血症患者的结果和指导治疗策略.
科学领域:
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
- 生物标志物 生物标志物
背景情况:
- 败血症是一种危及生命的器官功能障碍,是由宿主对感染反应失调引起的.
- 细胞因子表达在炎症级联和败血症的临床结果中起着至关重要的作用.
- 确定可靠的预后标志物对于及时干预和改善患者存活率至关重要.
研究的目的:
- 在败血症患者中研究各种细胞因子的表达水平.
- 确定细胞因子水平与患者预后之间的关联.
- 评估临床和炎症标志物对败血症结果的预测价值.
主要方法:
- 对在ICU治疗的227名败血症患者的临床数据的回顾性分析.
- 对细胞因子 (IL-2,IL-4,IL-6,IL-10,IL-17,TNF-α,IFN-γ) 的测量,APACHE II评分,PCT和CRP.
- 生存和死亡组之间的标记物的比较;二元物流回归和ROC曲线分析用于预后值.
主要成果:
- 与生存组相比,死亡组的APACHE II分数和PCT水平显著更高.
- 升高的IL-6水平与败血症患者的死亡率增加显著相关.
- APACHE II评分 (OR 1.050) 和IL-6 (OR 1.001) 被确定为败血症预后的独立危险因素.
结论:
- 亚帕希II分数和IL-6水平是败血症患者预后的有价值预测指标.
- 较高的APACHE II分数和IL-6水平与更高的死亡概率相关.
- 这些标志物可以帮助风险分层和治疗败血症的临床决策.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K


